Price $25.56 |
Market Cap
268.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
95.8
|
P/B
34.93
|
P/S
4.96
|
Dividend %
-
|
|
P/CF
52.3
|
P/FCF
71.3
|
Op. Cash Flow
7.7K
|
FCF
0.2
|
|
Op. Margin
5.60%
|
Net Margin
5.40%
|
ROE
47.40%
|
ROI
59.40%
|
|
ROA
6.30%
|
EPS Growth
71.30%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $9.86 | - | - | 9.5B | Strong Buy |
| Endo International PLC (ENDP) | $5.48 | - | - | 1.09B | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $27.55 | - | - | 872.6M | Strong Buy |
| Great Elm Capital Group Inc (GEC) | $2.76 | - | - | 53.7M | Strong Buy |
| NuVasive, Inc. (NUVA) | $48.03 | - | - | 2.53B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
